Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Category: Pharma Industry
Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...] …
Breaking News
Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate
French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...] …
Katheryne Richardson, a former senior global pricing strategist at Bristol-Myers Squibb (BMS) and longtime vice president of Apexus, this week [...] …
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
The federal government is pushing back against Sanofi’s lawsuit demanding the release of up to 7,500 records of 340B contract [...] …
A Maryland federal judge recently granted an influential drug industry trade group’s request to dismiss its 2021 lawsuit challenging a [...] …
Breaking News
Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...] …
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...] …
Drugmakers AbbVie and GlaxoSmithKline (GSK) will refund 340B providers for some products following ceiling price recalculations, according to notices posted [...] …